Young John Alexander sold $203K of AMBA

Ambarella (AMBA) may have a second potential buyer, following reports of NXP Semiconductors (NXPI) exploring an acquisition. Traders suggest a bid of 75% cash and 25% shares, valued between $95 and $105 per share, citing a Betaville alert. The identity of the new suitor is unknown.

Ambarella and ZEDEDA announced a partnership on September 15, 2026, integrating ZEDEDA's EVE-OS with Ambarella's N1 edge AI chips. The deal targets the $30B edge AI market, with developer kits expected in Q4 2026. Ambarella reported Q2 2026 revenue of $108.1M, up 13.2% YoY, while ZEDEDA has raised over $129M in funding.

Ambarella (AMBA) launched X7, a standalone AI accelerator chip, on September 15, 2026. X7 adds AI capabilities to existing systems without redesign, operating within 2-5 watts. It supports various AI models and is available for sampling. AMBA stock gained 1.98% post-announcement, trading at $65.25.

Ambarella CEO Feng-Ming Wang highlighted growth opportunities in edge AI across security, automotive, and wearables. He noted the company's competitive advantages in power efficiency and partnerships with Aurora, Continental, and Bosch. Automotive accounts for 30% of revenue, with potential for large design wins. Wang expects 10-15% revenue growth for fiscal 2027, citing broader edge AI adoption and stable gross margins.

Ambarella (AMBA) reported Q2 2027 revenue of $108.1M, up 13.2% YoY, slightly exceeding guidance. Non-GAAP gross margin was 59.3%, below midpoint due to product mix changes. Automotive revenue hit record levels, and IoT segment grew sequentially. The company forecasted a serviceable addressable market growing to $22.9B by 2032. Q3 revenue guidance is $115M to $124M, with non-GAAP gross margin expected between 59.0% and 60.0%. Management noted risks from memory price surges and supply chain costs.

Caleres Inc (CAL) reported Q2 earnings of $0.47 per share, beating estimates of $0.37, and raised FY26 EPS guidance. Shares rose 14.4% to $13.76. Other companies like Opus Genetics (IRD), Signet Jewelers (SIG), and Flotek Industries (FTK) also saw significant gains due to positive updates.